Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing

Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin-releasing hormone (GnRH) antagonist (ant) treatme...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Med Rep
Hoofdauteurs: GIZZO, SALVATORE, ANDRISANI, ALESSANDRA, NOVENTA, MARCO, MANFÈ, SERENA, OLIVA, ALESSANDRA, GANGEMI, MICHELE, NARDELLI, GIOVANNI BATTISTA, AMBROSINI, GUIDO
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: D.A. Spandidos 2015
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526099/
https://ncbi.nlm.nih.gov/pubmed/26059981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.3904
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items